Bio-Techne Corp (TECH) Stock Price, Quote & News

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth f...

Industry: Biotechnology

Sector: Healthcare

Phone: 612 379 8854

Fax: 612 656 4400

Website: www.bio-techne.com

Address:

614 McKinley Place N.E., Minneapolis, United States

Estimize Aug. 12 at 11:09 AM

$TECH reported 0.52 EPS and 321.19 revenue for Q4. http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_content=TECH&utm

0 · Reply

STRelativeStrength Aug. 10 at 7:06 PM

$TECH undiscovered breakout with 677 watchers

1 · Reply

Estimize Aug. 5 at 10:01 AM

Wall St is expecting 0.44 EPS for $TECH Q1 [Reporting 11/03 BMO] http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_co

0 · Reply

VirginiaLittle324 Aug. 5 at 6:58 AM

$MICC $TECH $BPOP $WTRG $JKHY MICC remains execution-driven, Bio-Techne benefits from life sciences demand, Popular strengthens Puerto Rican banking, Essential Utilities provides regulated water services, and Jack Henry leads community banking software.

0 · Reply

Alice68 Aug. 4 at 4:55 PM

Stock market today: Nasdaq surges, Dow and S&P 500 trade at record highs amid US-Iran optimism, tech rally stocks boosted the major indexes on Tuesday morning as markets eyed Middle East talks and earnings rolled in, with the arrival of $TECH SpaceX's (SPCX) earnings after the bell in focus.

0 · Reply

BostonDave Jul. 24 at 10:07 AM

$ALT $APGE $FOLD $TECH $TERN

0 · Reply

BuddyBoy6975 Jul. 24 at 1:29 AM

$ALT $APGE $FOLD $TECH $TERN So, in your Tern chart, short interest increased over a 6 month period by 1.5-2.5 times its SI 6 months earlier. Wow. Then hit Not fairy tale gobbledygook. Legitimate. Market. Analysis. 👏👏👏👏👏👏👏👏👏👏

0 · Reply

TradeSun Jul. 23 at 5:49 PM

$ALT $APGE $FOLD $TECH Short interest of $TERN kept growing and were running into Merck s BO- Offer on March 25 😉👇

1 · Reply

BuddyBoy6975 Jul. 23 at 1:57 AM

$ALT $APGE $FOLD $TECH Trade, interesting thoughts on WHY we see rising short interest and an increase in Bashers ahead of BO news…

0 · Reply

TradeSun Jul. 22 at 10:01 PM

$ALT $APGE $FOLD $TECH What I can tell you without any more dd, Dilution is not uncommon before a deal. Basta!

1 · Reply

Bio-Techne Corrects Dividend Announcement

Aug 12, 2026, 7:19 AM EDT - 2 days ago

Bio-Techne beats revenue estimates on research, diagnostics demand uptick

Aug 12, 2026, 6:30 AM EDT - 2 days ago

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Aug 12, 2026, 6:30 AM EDT - 2 days ago

Bio-Techne Declares Dividend

Aug 12, 2026, 6:00 AM EDT - 2 days ago

Bio-Techne Earnings release: Q4 2026

Aug 10, 2026, 8:00 AM EDT - 4 days ago

Bio-Techne Proxy statement: Proxy filing

Jul 9, 2026, 8:00 AM EDT - 5 weeks ago

Bio-Techne Proxy statement: Proxy filing

2026-07-09T09:40:19.000Z - 5 weeks ago

Bio-Techne downgraded to Sector Perform from Outperform at RBC Capital

Jul 8, 2026, 6:30 AM EDT - 5 weeks ago

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

Jul 6, 2026, 12:17 PM EDT - 5 weeks ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)

ACA IRDM

2026-07-06T12:41:45.000Z - 5 weeks ago

Bio-Techne downgraded to In Line from Outperform at Evercore ISI

2026-06-30T11:10:17.000Z - 6 weeks ago

Bio-Techne downgraded to Hold from Buy at Benchmark

2026-06-29T21:40:09.000Z - 6 weeks ago

Bio-Techne downgraded to Hold from Buy at TD Cowen

2026-06-26T21:00:17.000Z - 6 weeks ago

Bio-Techne downgraded to Neutral from Buy at Citi

2026-06-26T12:30:47.000Z - 7 weeks ago

Bio-Techne downgraded to Equal Weight from Overweight at Stephens

2026-06-26T10:45:32.000Z - 7 weeks ago

Bio-Techne price target raised to $73 from $49 at Baird

2026-06-26T08:35:23.000Z - 7 weeks ago

Bio-Techne downgraded to Hold from Buy at Deutsche Bank

2026-06-25T22:05:09.000Z - 7 weeks ago

Bio-Techne downgraded to Market Perform from Outperform at William Blair

2026-06-25T16:05:08.000Z - 7 weeks ago

Bio-Techne rises 19.7%

2026-06-25T15:25:15.000Z - 7 weeks ago

Bio-Techne downgraded to Market Perform from Outperform at Leerink

2026-06-25T14:00:12.000Z - 7 weeks ago

Bio-Techne rises 19.2%

Jun 25, 2026, 8:00 AM EDT - 7 weeks ago

Bio-Techne Proxy statement: Proxy filing

Jun 25, 2026, 7:18 AM EDT - 7 weeks ago

Germany's Merck Is Buying Bio-Techne for $11.3 Billion

2026-06-25T10:20:20.000Z - 7 weeks ago

Merck KGaA to acquire Bio-Techne for $73 per share in cash

Jun 25, 2026, 6:10 AM EDT - 7 weeks ago

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Jun 25, 2026, 6:09 AM EDT - 7 weeks ago

Germany's Merck to buy Bio-Techne for $73 per share

Jun 25, 2026, 6:08 AM EDT - 7 weeks ago

Germany's Merck to Buy Bio-Techne for $11 Billion

2026-06-23T11:28:57.000Z - 7 weeks ago

Bio-Techne named a best smid-cap idea at TD Cowen

2026-06-11T09:57:41.000Z - 2 months ago

Bio-Techne initiated with a Neutral at Piper Sandler

Jun 4, 2026, 6:30 AM EDT - 2 months ago

Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

May 12, 2026, 12:20 PM EDT - 3 months ago

Bio-Techne Transcript: Bank of America Global Healthcare Conference 2026

May 6, 2026, 9:00 AM EDT - 3 months ago

Bio-Techne Earnings Call Transcript: Q3 2026

May 6, 2026, 9:00 AM EDT - 3 months ago

Bio-Techne Earnings release: Q3 2026

May 6, 2026, 9:00 AM EDT - 3 months ago

Bio-Techne Quarterly report: Q3 2026

May 6, 2026, 7:21 AM EDT - 3 months ago

Bio-Techne misses revenue estimates as US academic funding cuts dent demand

May 6, 2026, 6:30 AM EDT - 3 months ago

Bio-Techne Releases Third Quarter Fiscal 2026 Results

May 4, 2026, 7:00 AM EDT - 3 months ago

Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

Apr 14, 2026, 7:00 AM EDT - 4 months ago

Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

Mar 25, 2026, 6:30 AM EDT - 5 months ago

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

Mar 10, 2026, 8:40 AM EDT - 5 months ago

Bio-Techne Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 11:10 AM EST - 5 months ago

Bio-Techne Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 7:00 AM EST - 6 months ago

Bio-Techne to Present at Upcoming Investor Conferences

Feb 16, 2026, 6:30 AM EST - 6 months ago

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Feb 11, 2026, 9:00 AM EST - 6 months ago

Bio-Techne Announces Changes to its Leadership Team

Feb 4, 2026, 9:00 AM EST - 6 months ago

Bio-Techne Earnings Call Transcript: Q2 2026

Feb 4, 2026, 9:00 AM EST - 6 months ago

Bio-Techne Quarterly report: Q2 2026

Feb 4, 2026, 9:00 AM EST - 6 months ago

Bio-Techne Earnings release: Q2 2026

Feb 4, 2026, 8:11 AM EST - 6 months ago

Biotech firm Bio-Techne beats quarterly estimates on strength in key unit

Feb 4, 2026, 6:30 AM EST - 6 months ago

Bio-Techne Releases Second Quarter Fiscal 2026 Results

Feb 2, 2026, 6:30 AM EST - 6 months ago

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

Jan 28, 2026, 6:30 AM EST - 7 months ago

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

Jan 20, 2026, 7:00 AM EST - 7 months ago

Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results

Jan 13, 2026, 12:00 PM EST - 7 months ago

Bio-Techne Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 8:00 PM EST - 7 months ago

Bio-Techne Slides: Corporate presentation

Dec 23, 2025, 7:00 AM EST - 8 months ago

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

Dec 9, 2025, 6:30 AM EST - 8 months ago

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

Dec 9, 2025, 4:30 AM EST - 8 months ago

Bio-Techne Transcript: 53rd Annual Nasdaq Investor Conference

Dec 3, 2025, 3:15 PM EST - 9 months ago

Bio-Techne Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 8:20 AM EST - 9 months ago

Bio-Techne Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 20, 2025, 7:30 AM EST - 9 months ago

Bio-Techne Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 9:00 AM EST - 9 months ago

Bio-Techne Transcript: Stephens Annual Investment Conference

Nov 18, 2025, 6:30 AM EST - 9 months ago

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

Nov 11, 2025, 9:20 AM EST - 9 months ago

Bio-Techne Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 10:15 AM EST - 9 months ago

Bio-Techne Transcript: UBS Global Healthcare Conference 2025

Nov 5, 2025, 9:00 AM EST - 10 months ago

Bio-Techne Earnings Call Transcript: Q1 2026

Nov 5, 2025, 9:00 AM EST - 10 months ago

Bio-Techne Quarterly report: Q1 2026

Nov 5, 2025, 9:00 AM EST - 10 months ago

Bio-Techne Earnings release: Q1 2026

Nov 5, 2025, 7:22 AM EST - 10 months ago

Bio-Techne misses quarterly sales estimates on weak biotech demand

Nov 5, 2025, 6:30 AM EST - 10 months ago

Bio-Techne Releases First Quarter Fiscal 2026 Results

Nov 5, 2025, 6:30 AM EST - 10 months ago

BIO-TECHNE DECLARES DIVIDEND

Nov 4, 2025, 9:01 AM EST - 10 months ago

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

Nov 3, 2025, 7:00 AM EST - 10 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

Oct 30, 2025, 9:00 AM EDT - 10 months ago

Bio-Techne Transcript: AGM 2025

Oct 28, 2025, 6:30 AM EDT - 10 months ago

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research

Oct 23, 2025, 7:00 AM EDT - 10 months ago

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital

Oct 15, 2025, 9:00 AM EDT - 10 months ago

Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents

Oct 15, 2025, 7:00 AM EDT - 10 months ago

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

Oct 9, 2025, 7:00 AM EDT - 11 months ago

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

Sep 26, 2025, 6:30 AM EDT - 11 months ago

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

Sep 24, 2025, 6:59 AM EDT - 11 months ago

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report

Sep 19, 2025, 8:00 AM EDT - 11 months ago

Bio-Techne Proxy statement: Proxy Filing

Sep 19, 2025, 8:00 AM EDT - 11 months ago

Bio-Techne Proxy statement: Proxy Filing

Sep 10, 2025, 10:45 AM EDT - 1 year ago

Bio-Techne Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 9:05 AM EDT - 1 year ago

Bio-Techne Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 7:00 AM EDT - 1 year ago

ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California

Sep 3, 2025, 10:15 AM EDT - 1 year ago

Bio-Techne Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory

Aug 6, 2025, 9:00 AM EDT - 1 year ago

Bio-Techne Earnings Call Transcript: Q4 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

Bio-Techne Annual report: Q4 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

Bio-Techne Earnings release: Q4 2025

Aug 6, 2025, 8:08 AM EDT - 1 year ago

Bio-Techne beats quarterly estimates on strength in protein sciences unit

Aug 6, 2025, 6:30 AM EDT - 1 year ago

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Bio-Techne Announces Exosome Diagnostics Divestiture

Aug 5, 2025, 7:00 AM EDT - 1 year ago

ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine

Jul 31, 2025, 9:52 AM EDT - 1 year ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY PODD

Estimize Aug. 12 at 11:09 AM

$TECH reported 0.52 EPS and 321.19 revenue for Q4. http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_content=TECH&utm

0 · Reply

STRelativeStrength Aug. 10 at 7:06 PM

$TECH undiscovered breakout with 677 watchers

1 · Reply

Estimize Aug. 5 at 10:01 AM

Wall St is expecting 0.44 EPS for $TECH Q1 [Reporting 11/03 BMO] http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_co

0 · Reply

VirginiaLittle324 Aug. 5 at 6:58 AM

0 · Reply

Alice68 Aug. 4 at 4:55 PM

0 · Reply

BostonDave Jul. 24 at 10:07 AM

$ALT $APGE $FOLD $TECH $TERN

0 · Reply

BuddyBoy6975 Jul. 24 at 1:29 AM

0 · Reply

TradeSun Jul. 23 at 5:49 PM

$ALT $APGE $FOLD $TECH Short interest of $TERN kept growing and were running into Merck s BO- Offer on March 25 😉👇

1 · Reply

BuddyBoy6975 Jul. 23 at 1:57 AM

$ALT $APGE $FOLD $TECH Trade, interesting thoughts on WHY we see rising short interest and an increase in Bashers ahead of BO news…

0 · Reply

TradeSun Jul. 22 at 10:01 PM

$ALT $APGE $FOLD $TECH What I can tell you without any more dd, Dilution is not uncommon before a deal. Basta!

1 · Reply

HansWurst19 Jul. 22 at 7:48 PM

$ALT $TECH $APGE $FOLD interesting. Have you matched it with the available shares of those companies? Maybe it's just that they diluted too and mire available shares meant more shorting? Or dilution means upcoming buyout?

1 · Reply

BuddyBoy6975 Jul. 22 at 7:33 PM

$ALT $APGE $FOLD $TECH Trade, that’s a HELLUVA find. Great job man….🙏🙏😎😎

1 · Reply

TradeSun Jul. 22 at 7:14 PM

$ALT $APGE $FOLD $TECH For FSDdingsbums… 👇 @Hatrak1

0 · Reply

TradeSun Jul. 2 at 1:25 PM

$ALT Regarding the question about growing short interest: I’ve noticed several times that short interest increased significantly and kept rising right up until the buyout of certain biotech companies. I asked ChatGPT to list the major biotech buyouts in 2026. The results are $TECH, $APGE, and $FOLD. Interestingly, all of them showed elevated or growing short interest leading up to the acquisition announcement. 👇

0 · Reply

LewisDaKat Jun. 26 at 10:30 AM

$TECH TECH Price Target Alert: $73.00. Issued by Deutsche Bank https://marketwirenews.com/stock/tech/news/tech-price-target-alert-73-00-issued-by-deutsche-ban-5447941763202062.html?utm_source=stocktwits

0 · Reply

LewisDaKat Jun. 26 at 10:00 AM

$TECH Hold Recommendation Issued On TECH By Deutsche Bank https://marketwirenews.com/stock/tech/news/hold-recommendation-issued-on-tech-by-deutsche-bank-5939493996299149.html?utm_source=stocktwits

0 · Reply

TNNStockAnalysisNews Jun. 26 at 5:58 AM

$AYI +21.5% $TECH +20.09% $MU +15.78% $SNDK +17.4% $QCOM +9% to +10% https://truthsandnews.com/markets/top-stock-gainers-today-june-25-2026

0 · Reply

LewisDaKat Jun. 25 at 10:00 PM

$TECH Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-PER-SHARE Cash Acquisition Offer https://marketwirenews.com/stock/tech/news/stock-market-today-june-25-bio-techne-surges-after-m-7238764970778849.html?utm_source=stocktwits

0 · Reply

LewisDaKat Jun. 25 at 6:30 PM

$TECH TECH Price Target Alert: $73.00. Issued by Leerink Partners https://marketwirenews.com/stock/tech/news/tech-price-target-alert-73-00-issued-by-leerink-part-7973092496092934.html?utm_source=stocktwits

0 · Reply

lecorb Jun. 25 at 4:54 PM

$MU $SNDK $TECH $BB $KYMR 👏🏼👏🏼👏🏼👊🏻👊🏻👊🏻

0 · Reply

TFars Jun. 25 at 3:40 PM

$TECH had a small position that I was building in my multi bagger account. Sold this morning. Getting bought out is definitely a risk when researching companies of this nature. On to finding a replacement or just adding to existing names.

0 · Reply

Market Cap	11.31B
Revenue (ttm)	1.22B
Net Income (ttm)	73.40M
EPS (ttm)	N/A
PE Ratio	41.47
Forward PE	40.99
Profit Margin	6.02%
Debt to Equity Ratio	0.10

Volume	1,228,278
Avg Vol	5,383,520
Day's Range	N/A - N/A
Shares Out	156.57M
Stochastic %K	56%
Beta	1.28
Analysts	Sell
Price Target	$69.61